Prostate Cancer

Novel Hormonal Therapies for nmCRPC Underused, Data Show

By

Jody A. Charnow

Publish Date September 30, 2022

Investigators characterized practice patterns in the first-line treatment of nonmetastatic castration-resistant prostate cancer using real-world data.

PRESTO: ADT Intensification Prolongs PSA PFS in Biochemically Recurrent Prostate Cancer

By

Jessica Nye, PhD

Publish Date September 29, 2022

Phase 3 results appear to support intensification of ADT in patients with biochemically recurrent prostate cancer.

Coffee Intake Linked to Longer Prostate Cancer-Specific Survival

Publish Date September 28, 2022

Longer prostate cancer-specific survival seen for specific subgroups, including those with the CYP1A2 AA genotype.

Prostate Cancer Survivors Weigh In on Visual Timelines of Patient-Reported Outcomes

By

Jennifer Larson

Publish Date September 27, 2022

Of 4 prototypes assessed, participants preferred meter as having the best gist comprehension and emoji as having the highest verbatim comprehension.

Longer Course of ADT With Postop Radiotherapy Improves Metastasis-Free Survival in Prostate Cancer

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date September 21, 2022

Adding a longer course of androgen deprivation therapy to postoperative radiotherapy may prolong metastasis-free survival in patients with prostate cancer.

Prostate Cancer Resources

Clinical Trials

Drug Monographs

Fact Sheets